Statements (462)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:disease
gptkb:diabetes gptkb:non-profit_organization gptkb:Hirogen gptkb:research_center gptkb:medical_devices |
| gptkbp:administered_by |
gptkb:Insulin_pen
gptkb:Insulin_pump Injection Syringe |
| gptkbp:advances |
in diabetes research and treatment
|
| gptkbp:advocacy |
gptkb:Stop_Diabetes_campaign
for healthcare professionals diabetes awareness healthcare access for all legislation for diabetes care support for diabetes patients |
| gptkbp:affects |
Liver
kidneys water balance blood sugar levels Muscle cells Fat cells |
| gptkbp:affiliated_with |
gptkb:University
|
| gptkbp:age_group |
gptkb:children
adults |
| gptkbp:aims_to |
Improve Patient Outcomes
|
| gptkbp:analysis |
Patient Samples
|
| gptkbp:annual_report |
financial statements
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:associated_with |
gptkb:disease
Cardiovascular disease Obesity obesity head trauma Metabolic syndrome pituitary gland disorders |
| gptkbp:available_on |
gptkb:Rapid-acting_insulin
gptkb:Short-acting_insulin Recombinant DNA technology Intermediate-acting insulin Long-acting insulin |
| gptkbp:awards |
recognition for diabetes research
|
| gptkbp:campaigns |
public awareness about diabetes
|
| gptkbp:can_be_configured_for |
Carbohydrate Counting
Basal Rates Bolus Doses |
| gptkbp:can_be_synthesized_by |
Recombinant DNA technology
|
| gptkbp:can_be_used_with |
Smartphone Apps
Continuous Glucose Monitors |
| gptkbp:can_include |
CGM Integration
|
| gptkbp:can_lead_to |
electrolyte imbalance
low blood pressure eye damage heart disease kidney damage nerve damage hypovolemia foot damage |
| gptkbp:caused_by |
genetic mutations
tumors certain medications infections insulin resistance deficiency of vasopressin surgery on the pituitary gland |
| gptkbp:certification |
Diabetes Education Accreditation Program
|
| gptkbp:charging_method |
USB Cable
Wall Adapter |
| gptkbp:charity |
Step Out: Walk to Stop Diabetes
to support diabetes research |
| gptkbp:collaborates_with |
Pharmaceutical Companies
Healthcare Institutions |
| gptkbp:collaboration |
with public health organizations
other diabetes organizations |
| gptkbp:collaborations |
partnerships with universities
with pharmaceutical companies |
| gptkbp:community_engagement |
local diabetes events
|
| gptkbp:community_health |
advocacy for diabetes-related legislation
to reduce diabetes prevalence |
| gptkbp:community_impact |
improving diabetes care access
|
| gptkbp:community_outreach |
to schools and communities
screening and education programs |
| gptkbp:community_programs |
local diabetes support groups
|
| gptkbp:community_support |
for diabetes patients and families
|
| gptkbp:complications |
eye damage
heart disease kidney damage nerve damage |
| gptkbp:condition |
dehydration
hypernatremia |
| gptkbp:conducts |
Epidemiological Studies
Behavioral Research Genetic Research Longitudinal Studies Pharmacological Studies |
| gptkbp:conducts_research_on |
gptkb:diabetes
gptkb:Type_1_Diabetes |
| gptkbp:conference |
educational events
|
| gptkbp:control_system |
gptkb:Insurance_Company
gptkb:Doctor |
| gptkbp:deficiency_causes |
Diabetes mellitus
|
| gptkbp:delivers |
gptkb:diabetes
|
| gptkbp:developed_by |
gptkb:Islets_of_Langerhans
|
| gptkbp:develops |
New Treatments
|
| gptkbp:diagnosis |
blood tests
urine tests MRI scan water deprivation test |
| gptkbp:discovered_by |
gptkb:1921
gptkb:Canada gptkb:Sir_Frederick_Banting gptkb:Charles_Best |
| gptkbp:education |
patient education programs
diabetes management programs |
| gptkbp:educational_resources |
online courses
|
| gptkbp:engages_in |
gptkb:Community_Outreach
|
| gptkbp:enhances |
Protein synthesis
Glycogenesis Glycogen synthesis |
| gptkbp:ethnicity |
higher risk in certain populations
|
| gptkbp:events |
gptkb:American_Diabetes_Association_Scientific_Sessions
|
| gptkbp:first_described_by |
1888
|
| gptkbp:first_introduced |
gptkb:diabetes
gptkb:1922 |
| gptkbp:focus |
diabetes research
|
| gptkbp:focuses_on |
gptkb:diabetes
|
| gptkbp:form |
Long-acting
Short-acting Hexamer Intermediate-acting Rapid-acting |
| gptkbp:founded |
gptkb:1940
|
| gptkbp:function |
Facilitates glucose uptake
|
| gptkbp:funding |
grants and donations
research grants grants for diabetes research |
| gptkbp:has_access_to |
Biobanks
Clinical Data |
| gptkbp:has_achieved |
gptkb:diabetes
chronic kidney disease psychogenic polydipsia |
| gptkbp:has_collaborated_with |
Non-Profit Organizations
|
| gptkbp:has_collaborations_with |
International Institutions
|
| gptkbp:has_component |
gptkb:reservoir
Infusion Set Pump Mechanism |
| gptkbp:has_developed |
Research Protocols
Educational Materials Mobile Health Applications |
| gptkbp:has_established |
gptkb:Partnerships
Research Networks Clinical Partnerships |
| gptkbp:has_lore |
can be cured completely
is not serious only affects adults only affects overweight people |
| gptkbp:has_programs_for |
Diabetes Management
Diabetes Prevention |
| gptkbp:has_publications |
Peer-Reviewed Articles
|
| gptkbp:has_type |
gptkb:Type_1_diabetes
Type 2 diabetes Gestational diabetes |
| gptkbp:headquarters |
gptkb:Arlington,_Virginia
|
| gptkbp:healthcare_provider_resources |
guidelines for diabetes care
|
| gptkbp:hosts |
Conferences
|
| https://www.w3.org/2000/01/rdf-schema#label |
diabetes
|
| gptkbp:impact |
advancing diabetes treatment and care
|
| gptkbp:influenced_by |
sleep quality
stress management dietary changes exercise routines |
| gptkbp:influences |
Cell differentiation
Cell growth Gene expression Inflammation Immune response Cell signaling pathways Fat storage Amino acid metabolism Lipid metabolism Appetite regulation Glucose metabolism Electrolyte balance Stress response Cellular repair mechanisms Brain function Energy homeostasis Vascular function Cellular growth and division |
| gptkbp:initiated_by |
Gluconeogenesis
Low blood sugar Lipolysis |
| gptkbp:initiatives |
Type 1 and Type 2 diabetes studies
|
| gptkbp:invention |
gptkb:University_of_Toronto
|
| gptkbp:involved_in |
Protein synthesis
Metabolism Fat storage Anabolic processes |
| gptkbp:is_active_in |
Clinical Research
Research Dissemination |
| gptkbp:is_associated_with |
Improved Quality of Life
Weight gain Increased Flexibility obesity family history Hypoglycemia sedentary lifestyle Reduced Hypoglycemia Risk |
| gptkbp:is_available_in |
Various Models
Wireless Models Adult Models Pediatric Models Tubeless Models |
| gptkbp:is_characterized_by |
insulin resistance
high blood sugar autoimmune destruction of beta cells dilute urine high urine output low urine specific gravity |
| gptkbp:is_common_in |
gptkb:children
adults elderly older adults minority groups obese individuals people with high blood pressure people with high cholesterol |
| gptkbp:is_compatible_with |
Various Insulin Types
|
| gptkbp:is_connected_to |
gptkb:Blood_Glucose_Monitor
|
| gptkbp:is_considered |
A Technological Advancement
A Lifesaving Device A Long-Term Solution A Personal Medical Device An Alternative to Injections |
| gptkbp:is_designed_for |
Subcutaneous Use
|
| gptkbp:is_designed_to |
Improve Glycemic Control
Minimize Injections |
| gptkbp:is_engaged_in |
Public Health Initiatives
Outreach Programs |
| gptkbp:is_focused_on |
Diabetes Complications
|
| gptkbp:is_involved_in |
Cell differentiation
Cell growth Cell signaling Inflammation Research Collaborations Immune response Patient Recruitment Cellular respiration Policy Advocacy Health Education Programs Aging process Cellular signaling pathways Growth and development Health Policy Research Clinical Trials Management Health Promotion Activities Hormonal balance Stress response Nucleotide synthesis Cellular repair mechanisms Energy homeostasis Cholesterol synthesis Fatty acid synthesis Nutrient sensing Clinical Guidelines Development Cellular energy production Metabolic flexibility Amino acid uptake Cellular adaptation. Nutrient partitioning Triglyceride synthesis |
| gptkbp:is_known_for |
Translational Research
Innovative Research Patient-Centered Research |
| gptkbp:is_linked_to |
gptkb:Cardiology
Cardiovascular disease Obesity stroke skin conditions Metabolic syndrome Insulin resistance dental problems |
| gptkbp:is_located_in |
gptkb:City
|
| gptkbp:is_managed_by |
gptkb:exercise
dietary changes insulin therapy continuous glucose monitoring insulin pumps blood sugar monitoring |
| gptkbp:is_monitored_by |
blood glucose levels
self-monitoring of blood glucose Hb A1c tests |
| gptkbp:is_often_compared_to |
Syringe
Insulin Pen |
| gptkbp:is_often_seen_in |
gptkb:Europe
gptkb:Asia gptkb:North_America |
| gptkbp:is_often_used_in |
gptkb:children
Adults Exercise Management Dietary Management Active Lifestyles Lifestyle Adjustments |
| gptkbp:is_part_of |
gptkb:health_services
Endocrinology Academic Consortium Diabetes Technology Diabetes Management Plans Insulin Delivery Systems |
| gptkbp:is_produced_in_response_to |
Food intake
|
| gptkbp:is_recognized_by |
National Organizations
|
| gptkbp:is_recognized_for |
Excellence in Research
|
| gptkbp:is_regulated_by |
gptkb:FDA
gptkb:Hirogen Glucose levels |
| gptkbp:is_related_to |
gptkb:posterior_pituitary
gptkb:hypothalamus gptkb:ADH_(antidiuretic_hormone) |
| gptkbp:is_secreted_in_response_to |
High blood sugar
|
| gptkbp:is_studied_in |
gptkb:medical_research
clinical trials genetic research epidemiology public health research nutrition science |
| gptkbp:is_subject_to |
gptkb:Clinical_Trials
User Feedback Insurance Coverage Policies Reimbursement Guidelines |
| gptkbp:is_supported_by |
Research Grants
Corporate Sponsorships Foundations |
| gptkbp:is_used_by |
Type 1 Diabetes Patients
Type 2 Diabetes Patients |
| gptkbp:is_used_for |
gptkb:Type_1_diabetes
Insulin Therapy Type 2 diabetes |
| gptkbp:is_used_in |
Clinical Settings
Home Care Settings |
| gptkbp:is_used_to |
Manage Blood Sugar Levels
|
| gptkbp:is_vulnerable_to |
Insulin receptor
|
| gptkbp:lifespan |
5 to 10 minutes
|
| gptkbp:made_of |
Medical Grade Materials
|
| gptkbp:marketed_as |
gptkb:Lantus
gptkb:Humulin gptkb:Novolog gptkb:Levemir Apidra |
| gptkbp:measures |
Blood tests
|
| gptkbp:membership |
gptkb:healthcare_professionals
|
| gptkbp:membership_benefits |
access to research and resources
|
| gptkbp:mission |
prevent and cure diabetes
|
| gptkbp:network |
for healthcare professionals
|
| gptkbp:number_of_players |
millions affected worldwide
increased risk of comorbidities rising incidence rates significant healthcare costs |
| gptkbp:offers |
gptkb:Telehealth_Services
gptkb:Workshops gptkb:Clinical_Trials Internships Fellowship Programs Patient Resources |
| gptkbp:partnership |
for diabetes innovation
|
| gptkbp:partnerships |
corporate sponsors
|
| gptkbp:patient_education |
workshops and seminars
|
| gptkbp:patient_population |
diabetes self-management tools
|
| gptkbp:policy_statements |
healthcare policy recommendations
|
| gptkbp:prevalence |
increasing globally
1 in 25,000 |
| gptkbp:prevention |
regular exercise
weight management healthy diet |
| gptkbp:produced_by |
Pancreas
Beta cells |
| gptkbp:promotes |
Healthy Lifestyles
Glucose uptake |
| gptkbp:provides |
Mental Health Support
Patient Education Support Groups Nutritional Counseling Genetic Counseling Continuous Insulin Delivery |
| gptkbp:provides_guidance_on |
gptkb:diabetes
gptkb:World_Health_Organization nutrition and physical activity recommendations |
| gptkbp:publication |
Diabetes Care
|
| gptkbp:publications |
diabetes education materials
research articles and journals |
| gptkbp:publishes |
Research Findings
|
| gptkbp:receives_funding_from |
Government Grants
Private Donations |
| gptkbp:regulates |
Blood glucose levels
|
| gptkbp:replaces |
gptkb:1921
|
| gptkbp:requires |
Regular Maintenance
Training for Use |
| gptkbp:research |
clinical trials
ongoing studies |
| gptkbp:research_focus |
Metabolic disorders
Diabetes treatment Obesity management |
| gptkbp:research_importance |
diabetes prevention and management
|
| gptkbp:risk_factor |
family history
sedentary lifestyle |
| gptkbp:school_events |
conferences and workshops
|
| gptkbp:scientific_classification |
chronic condition
|
| gptkbp:security |
Pancreatic islets
|
| gptkbp:social_media_presence |
Facebook, Twitter, Instagram
|
| gptkbp:structure |
A and B chains
|
| gptkbp:support |
support groups
healthcare providers family involvement |
| gptkbp:symptoms |
fatigue
frequent urination increased thirst blurred vision blurry vision extreme fatigue excessive thirst excessive urination slow healing sores |
| gptkbp:trains |
gptkb:healthcare_professionals
|
| gptkbp:transportation |
Bloodstream
|
| gptkbp:treatment |
gptkb:Type_1_diabetes
medications DPP-4 inhibitors GLP-1 receptor agonists SGLT2 inhibitors lifestyle changes improving quality of life Type 2 diabetes maintaining a healthy weight oral medications insulin therapy desmopressin bariatric surgery thiazide diuretics hydration therapy thiazolidinediones achieving normal blood sugar levels reducing complications non-steroidal anti-inflammatory drugs insulin injections |
| gptkbp:type |
gptkb:central_diabetes_insipidus
gptkb:nephrogenic_diabetes_insipidus gptkb:protein gestational diabetes insipidus |
| gptkbp:used_for |
Diabetes Management
|
| gptkbp:used_in |
Insulin therapy
|
| gptkbp:utilizes |
Advanced Technology
|
| gptkbp:volunteer_opportunities |
community outreach
for community service |
| gptkbp:was_educated_at |
complications
nutrition diabetes management exercise benefits |
| gptkbp:website |
diabetes.org
|
| gptkbp:weight |
5808 Da
|
| gptkbp:bfsParent |
gptkb:Willie_Nelson
gptkb:National_Institutes_of_Health |
| gptkbp:bfsLayer |
3
|